Navigation Links
Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
Date:10/13/2008

HOPKINTON, Mass., Oct. 13 /PRNewswire/ -- Facet Solutions, Inc. today announced the completion of 6 month follow-up on 20 patients from its US IDE Pilot Study. The results show a 78% reduction in Oswestry Disability Index (ODI) scores, and an 80% reduction in Visual Analog Scores (VAS) for symptomatic leg pain. Geoff Pardo, President & CEO for Facet Solutions, added, "We are very pleased with these early results, which thus far not only demonstrate significant pain relief but the safety of an anatomic and unconstrained design."

Dr. John Regan, of St. Johns Hospital in Santa Monica, CA, will be presenting the results from Facet Solutions' US Pilot Study at 11:17am on Tuesday, October 14th at the NASS Pre-Meeting Course in Toronto, Ontario.

Facet Solutions, Inc. has developed the ACADIA(TM) Facet Replacement System (AFRS(TM)) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA(TM) procedure includes replacement of the diseased facet joint with an anatomic implant that is designed to restore the natural motion, stability, and balance to the lumbar spine.

*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is certified to ISO 13485. The company will be attending the upcoming North American Spine Surgeons Meeting in Toronto, Ontario (booth #1406).


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. First Human Implant of New Archus Orthopedics Facet Replacement System
4. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
7. DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0
8. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
9. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
10. Aon eSolutions Launches Clinical Trials Module
11. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....25/PRNewswire/-- ChemoCentryx,Inc.,announcedtoda...T-1(theProspectiveRandomizedOralTherapyEvaluationi...patientswithmoderate-to-severeCrohn,sdiseasedemons...abilityprofile.Thestudydemonstratedevidenceofclini...dasa70-pointdecreaseintheCrohn,sDiseaseActivityInd...
(Date:11/24/2009)...ewswire-FirstCall/--QuestDiagnosticsIncorporated(N...sting,informationandservices,announcedthatitissche...onferenceinNewYorkCity.Thepresentationisscheduledf..., Duringtheconference,thecompanywillreaffirmits...ingincometoexceed18%ofrevenues,anddilutedearningsp...
(Date:11/24/2009)...wswire/--Inadditiontofamily,friendsandhealth,cance...herThanksgivinggratitudelist. ,, "Theyheardthef...aidofMonday,sverdictstotaling$103millionindamagesa...2,000womennationwidewhohavesuedWyethandPfizerpharm...ndPrempro.Wisneskiandtheothervictimsofhormonethera...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 1Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 1Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 3AOBO Launches New OTC Product to Treat Throat Inflammation 14001 1AOBO Launches New OTC Product to Treat Throat Inflammation 14001 2
... Md., April 27 As body mass increases, so does ... according to Baltimore researchers. A new study, ...f the American Urological Association (AUA), asses...luated insurance claims of 95,962 subjects over a ...ify whether obesity is associated with a UTI diagn...
... Build on Pivotal Phase III Study for the Treatmen...., April 27 Ferring Pharmaceuticals announced tod...garelix for injection, a new injectable gonadotrop...proved by the U.S. Food and Drug Administration (F...d prostate cancer. The announcement was made at...
Other Medicine Technology:Obesity Associated With Higher Risk for Urinary Tract Infections 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...OandCALGARY,Nov.25/PRNewswire/-SentinelleMedicalIn...MRI)coilsandsoftwareandCalgaryScientificInc.,alead...oducedawebversionofAegis(TM)Breast4DAdvancedVisual...efirsttrulyzero-footprintWebclientbasedmedicalimag...TM)platformallowsforzero-footprintaccess-requiring...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ns of deep concern and disappointment about report...orward without addressing several issues that are ...ies were sent today to congressional leaders by th... and medical student members of ACP. , Dr. Dale t...
... 20, 2007) A Jekyll-Hyde mechanism that both prot...be the basis for new cancer-fighting drugs. , Sci...n Lindquist have discovered that a certain transcr...s the survival of cancer cells. , According to t...
...ose research is challenging conventional thinking ...fit cardiac patients, has secured funding to furth...from the Universitys Faculty of Biological Science...For a long time the cardiovascular benefits of sta...
...he job the agency is doing , , THURSDAY, ...Americans depend on prescription medicines for hea...nt,s role in keeping those medicines safe, a new s...ged the agency,s performance as poor. , "The Ameri...
... Developments in Solid Organ Transplantation, DAL...w",is the focus of a one-day meeting scheduled for...exas. Co-sponsored by the American Society of,Tran...ents in solid organ transplantation medicine and h...
...Enables Health Care Providers to Increase ...s, SAN ANTONIO, Sept. 20 AT&T Inc. (NYSE: T ),t...folio of radio frequency,identification (RFID) tra...AT&T is the first network services company to prov...
Other Medicine News:Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Heat shock proteins are co-opted for cancer 2Health News:Research to shed new light on how statins benefit heart patients 2Health News:Americans Confused About FDA and Drug Safety 2Health News:Americans Confused About FDA and Drug Safety 3Health News:Americans Confused About FDA and Drug Safety 4Health News:Dallas-Area Transplant Meeting Puts Spotlight on Key Issues 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 3
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...roscopic condenser humidifiers (HCH) capture the p... in the inspired gas. Small and compact, they are ...groscopic benefits. Depending on the tidal volume ...ume model., ,The adult HCH is ideal for patient t...
Medicine Products: